Supportive role of a micronutrient appetite normaliser in convalescing patients.
A total of 722 patients recruited from various clinics across Western India, particularly in Western Maharashtra and South Gujarat, recovering from a variety of clinical conditions such as infections of the respiratory tract, malaria, enteric fever, jaundice, surgical procedures and so on were administered a micronutrient appetite normaliser formulation (neogadine) for periods up to 30 days. There was a significant and steady increase in the scores of appetite and well-being during the study period. Very good to good response were reported in 83% of patients. Neogadine was well tolerated with no significant adverse effects on any patients. Based on past experience with this micronutrient formulation as well as the findings of the present study, it is reasonable to conclude that neogadine plays a useful supportive role in the restoration of appetite and well-being in conditions that apply to private practice situations in India.
Madan
Z M
ZM
D000328:Adult; D000855:Anorexia / Q000188:drug therapy* / Q000209:etiology; D019167:Appetite Stimulants / Q000009:adverse effects / Q000627:therapeutic use*; D003289:Convalescence; D003906:Developing Countries; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007194:India; D008297:Male; D018977:Micronutrients / Q000008:administration & dosage* / Q000009:adverse effects; D011788:Quality of Life; D016896:Treatment Outcome; D014815:Vitamins / Q000008:administration & dosage* / Q000009:adverse effects
D019167:Appetite Stimulants; D004338:Drug Combinations; D018977:Micronutrients; D014815:Vitamins